» Articles » PMID: 24350582

Improvement in Rheumatic Fever and Rheumatic Heart Disease Management and Prevention Using a Health Centre-based Continuous Quality Improvement Approach

Overview
Publisher Biomed Central
Specialty Health Services
Date 2013 Dec 20
PMID 24350582
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rheumatic heart disease (RHD) remains a major health concern for Aboriginal Australians. A key component of RHD control is prevention of recurrent acute rheumatic fever (ARF) using long-term secondary prophylaxis with intramuscular benzathine penicillin (BPG). This is the most important and cost-effective step in RHD control. However, there are significant challenges to effective implementation of secondary prophylaxis programs. This project aimed to increase understanding and improve quality of RHD care through development and implementation of a continuous quality improvement (CQI) strategy.

Methods: We used a CQI strategy to promote implementation of national best-practice ARF/RHD management guidelines at primary health care level in Indigenous communities of the Northern Territory (NT), Australia, 2008-2010. Participatory action research methods were employed to identify system barriers to delivery of high quality care. This entailed facilitated discussion with primary care staff aided by a system assessment tool (SAT). Participants were encouraged to develop and implement strategies to overcome identified barriers, including better record-keeping, triage systems and strategies for patient follow-up. To assess performance, clinical records were audited at baseline, then annually for two years. Key performance indicators included proportion of people receiving adequate secondary prophylaxis (≥80% of scheduled 4-weekly penicillin injections) and quality of documentation.

Results: Six health centres participated, servicing approximately 154 people with ARF/RHD. Improvements occurred in indicators of service delivery including proportion of people receiving ≥40% of their scheduled BPG (increasing from 81/116 [70%] at baseline to 84/103 [82%] in year three, p = 0.04), proportion of people reviewed by a doctor within the past two years (112/154 [73%] and 134/156 [86%], p = 0.003), and proportion of people who received influenza vaccination (57/154 [37%] to 86/156 [55%], p = 0.001). However, the proportion receiving ≥80% of scheduled BPG did not change. Documentation in medical files improved: ARF episode documentation increased from 31/55 (56%) to 50/62 (81%) (p = 0.004), and RHD risk category documentation from 87/154 (56%) to 103/145 (76%) (p < 0.001). Large differences in performance were noted between health centres, reflected to some extent in SAT scores.

Conclusions: A CQI process using a systems approach and participatory action research methodology can significantly improve delivery of ARF/RHD care.

Citing Articles

Quality indicators for the primary prevention of cardiovascular disease in primary care: A systematic review.

Bam K, Olaiya M, Cadilhac D, Redfern J, Nelson M, Sanders L PLoS One. 2024; 19(12):e0312137.

PMID: 39637114 PMC: 11620663. DOI: 10.1371/journal.pone.0312137.


Adherence to secondary antibiotic prophylaxis among patients with acute rheumatic fever and/or rheumatic heart disease: a systematic review and meta-analysis.

Bimerew M, Araya F, Ayalneh M BMJ Open. 2024; 14(11):e082191.

PMID: 39542478 PMC: 11575240. DOI: 10.1136/bmjopen-2023-082191.


Living with rheumatic fever and rheumatic heart disease in Victoria, Australia: A qualitative study.

Oliver J, Fualautoalasi-Lam L, Ferdinand A, Tiatia R, Jones B, Engelman D PLoS Negl Trop Dis. 2024; 18(8):e0012038.

PMID: 39213445 PMC: 11392276. DOI: 10.1371/journal.pntd.0012038.


Prevalence and pattern of rheumatic valvular heart disease in Africa: Systematic review and meta-analysis, 2015-2023, population based studies.

Abdu S, Kassaw A, Tareke A, Mankelkl G, Belete M, Bihonegn M PLoS One. 2024; 19(7):e0302636.

PMID: 39074103 PMC: 11285969. DOI: 10.1371/journal.pone.0302636.


Preventive Interventions to Reduce the Burden of Rheumatic Heart Disease in Populations at Risk: A Systematic Review.

Shimanda P, Shumba T, Brunstrom M, Iipinge S, Soderberg S, Lindholm L J Am Heart Assoc. 2024; 13(5):e032442.

PMID: 38390809 PMC: 10944073. DOI: 10.1161/JAHA.123.032442.


References
1.
Ralph A, Carapetis J . Group a streptococcal diseases and their global burden. Curr Top Microbiol Immunol. 2012; 368:1-27. DOI: 10.1007/82_2012_280. View

2.
Carapetis J, Wolff D, Currie B . Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory. Med J Aust. 1996; 164(3):146-9. DOI: 10.5694/j.1326-5377.1996.tb122012.x. View

3.
Jaine R, Baker M, Venugopal K . Epidemiology of acute rheumatic fever in New Zealand 1996-2005. J Paediatr Child Health. 2008; 44(10):564-71. DOI: 10.1111/j.1440-1754.2008.01384.x. View

4.
Harrington Z, Thomas D, Currie B, Bulkanhawuy J . Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust. 2006; 184(10):514-7. DOI: 10.5694/j.1326-5377.2006.tb00347.x. View

5.
Bailie R, Si D, ODonoghue L, Dowden M . Indigenous health: effective and sustainable health services through continuous quality improvement. Med J Aust. 2007; 186(10):525-7. DOI: 10.5694/j.1326-5377.2007.tb01028.x. View